Target intelligence / Profile preview

SLC6A17 antisense RNA 1 (SLC6A17-AS1)

Target: SLC6A17-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

SLC6A17 antisense RNA 1 (SLC6A17-AS1) is a long non-coding RNA (lncRNA) gene transcribed from the opposite (antisense) strand of the SLC6A17 locus. It does not encode a protein, but like other antisense lncRNAs, it may play a regulatory role in controlling the expression of the neighboring SLC6A17 protein-coding gene or other targets. There is currently little published functional or disease association data for SLC6A17-AS1. It is not classified as a receptor, enzyme, transporter, or typical drug target and has no established clinical or drug interaction profile. The protein-coding gene SLC6A17 (solute carrier family 6 member 17) is a neutral amino acid vesicular transporter in the brain, but the antisense RNA (SLC6A17-AS1) is distinct and non-coding. No evidence was found in the results for SLC6A17-AS1 as a therapeutic target, receptor, or direct disease biomarker, nor for associated drugs, mechanisms, or safety issues.

Other names: SLC6A17-AS1SLC6A17 antisense RNA 1

Biological functions

Likely involved in gene regulation at the RNA level (antisense lncRNAs typically regulate expression of their sense gene counterparts, but specific functions are not documented)

Disease associations

Other (no established link to specific diseases is documented for SLC6A17-AS1, though dysregulation of lncRNAs can be associated with various conditions)

Beyond the preview

Go deeper on SLC6A17 antisense RNA 1 (SLC6A17-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC6A17 antisense RNA 1 (SLC6A17-AS1).

Explore the full profile